Selenium: African Studies Reported at Durban

DonateNow
Print this article

Selenium: African Studies Reported at Durban

AIDS TREATMENT NEWS Issue #347, July 28, 2000
John S. James


As usual, the International Conference on AIDS this year was weak on nutrition, but there was information in scattered abstracts and presentations. A search for 'selenium' found three abstracts, two of which concerned nutrition.

"Selenium deficiency is associated with shedding of HIV-1 infected cells in the female genital tract," by J. Baeten, S. Mostad, M. Hughes and others, abstract #MoOrA226, reported finding selenium deficiency in 11% of 318 women studied in Kenya. They found that the deficiency was associated with "a nearly 3-fold increased likelihood of shedding of genital mucosal HIV-1 DNA, suggesting that deficiency may increase the infectiousness of women with HIV-1." They suggested further study of nutritional approaches to reducing HIV transmission.

"Nutritional determinants of CD4+ T-cell counts in Ethiopians: a possible role for selenium?" by A. Cherinet, C.E. West, P. Versloot and others, abstract #MoPpB1016, reported that in HIV-positive Ethiopians, selenium levels were lower for those with more advanced HIV disease (as indicated by lower CD4 count). But in those who were HIV negative, higher selenium levels were found in those with lowest CD4 counts, for unknown reasons. The authors noted that Ethiopians generally have lower CD4 counts than international norms, also for reasons which are not known.
000728
ATN34704


Copyright © 2000 - AIDS Treatment News. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. AIDS Treatment News, Subscription and Editorial Office: 1233 Locust St., 5th floor Philadelphia, PA 19107 800/TREAT-1-2 toll-free email: aidsnews@critpath.org  http://www.aidsnews.org

Subscription Information: Call 800/TREAT-1-2: Businesses, Institutions, Professionals: $270/year. Includes early delivery of an extra copy by email. Nonprofit organizations: $135/year. Includes early delivery of an extra copy by email. Individuals: $120/year, or $70 for six months. Special discount for persons with financial difficulties: $54/year, or $30 for six months. If you cannot afford a subscription, please write or call. Outside North, Central, or South America, add air mail postage: $20/year, $10 for six months. Back issues available. Fax subscriptions, bulk rates, and multiple subscriptions are available; contact our office for details. Please send U.S. funds: personal check or bank draft, international postal money order, or travelers checks. VISA, Mastercard, and purchase orders also accepted. ISSN # 1052-4207

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2000. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2000. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .